高血糖对红细胞理化性质及免疫功能影响的研究进展*

doi:10.3969/j.issn.1671-2587.2021.05.029

临床输血与检验 ›› 2021, Vol. 23 ›› Issue (5): 677-680.DOI: 10.3969/j.issn.1671-2587.2021.05.029

• 综述 • 上一篇

高血糖对红细胞理化性质及免疫功能影响的研究进展^*

张紫薇, 周晓芳, 郭建荣

200135 海军军医大学附属公利医院（张紫薇,周晓芳,郭建荣）

收稿日期:2020-11-10 发布日期:2021-10-20
通讯作者: 郭建荣,男,博士后,教授,主任医师,博士生导师,主要从事围术期输血与血液保护研究,（E-mail）jianrguo@126.com。
作者简介:张紫薇（1995-）,女,安徽芜湖人,在读硕士,主要从事围术期输血与血液保护研究,（E-mail）zwzhang0618@163.com。
基金资助:
*本课题受国家自然科学基金面上项目（No. 81671919）、上海市浦东新区卫生系统重点学科群建设项目（No. PWZxq2017-10）资助

Received:2020-11-10 Published:2021-10-20

摘要/Abstract

摘要： 由于红细胞没有线粒体,其能量供应完全依赖于葡萄糖酵解,但高血糖状态可使血红蛋白糖化,产生氧化应激对细胞组分造成损伤。本文系统回顾糖尿病状态下红细胞的变化,分析糖尿病对红细胞理化性质及免疫功能的影响,以期为糖尿病患者的临床治疗提供参考。

关键词: 糖尿病, 红细胞, 理化性质, 免疫功能

中图分类号:

R587.2

张紫薇, 周晓芳, 郭建荣. 高血糖对红细胞理化性质及免疫功能影响的研究进展^*[J]. 临床输血与检验, 2021, 23(5): 677-680.

[1] CHO N H,SHAW J E,KARURANGA S,et al.IDF Diabetes Atlas:Global estimates of diabetes prevalence for 2017 and projections for 2045[J].Diabetes Res Clin Pract,2018,138:271-281.
[2] SZABLEWSKI L,SULIMA A.The structural and functional changes of blood cells and molecular components in diabetes mellitus[J].Biol Chem,2017,398(4):411-423.
[3] SAUDEK C D,DERR R L,KALYANI R R.Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c[J].JAMA,2006,295(14):1688-1697.
[4] ZHANG D D,TANG X,JIN D Y,et al.Prevalence of diabetes in Chinese adults:a Meta-analysis[J].Zhonghua Liu Xing Bing Xue Za Zhi,2018,39(6):852-857.
[5] 何银辉,徐海燕,付麒,等.糖化血红蛋白和病程对2型糖尿病胰岛β细胞功能的影响[J].南方医科大学学报,2019,39(9):1003-1008.
[6] CHU H W,MA Y J,HUANG Z H.A pilot study:effect of erythrocyte lifespan determined by a modified carbon monoxide breath test on glycosylated hemoglobin interpretation[J].J Breath Res,2020,14(2):027101.
[7] TANNER L B,GOGLIA A G,WEI M H,et al.Four key steps control glycolytic flux in mammalian cells[J].Cell Syst,2018,7(1):49-62.e8.
[8] MALI A V,BHISE S S,HEGDE M V,et al.Altered erythrocyte glycolytic enzyme activities in type-II diabetes[J].Indian J Clin Biochem,2016,31(3):321-325.
[9] BHISE S,RAO J,HEGDE M,et al.Type 2 diabetes differentially affects the substrate saturation kinetic attributes of erythrocyte hexokinase and phosphofructokinase[J].FEBS Lett,2020,594(2):240-250.
[10] MALI A V,BHISE S S,KATYARE S S,et al.Altered kinetics properties of erythrocyte lactate dehydrogenase in type II diabetic patients and its implications for lactic acidosis[J].Indian J Clin Biochem,2018,33(1):38-45.
[11] RICHARDS J P,YOSTEN G L C,KOLAR G R,et al.Low O₂-induced ATP release from erythrocytes of humans with type 2 diabetes is restored by physiological ratios of C-peptide and insulin[J].Am J Physiol Regul Integr Comp Physiol,2014,307(7):R862-R868.
[12] DUDZINSKA W.Purine nucleotides and their metabolites in patients with type 1 and 2 diabetes mellitus[J].JBiSE,2014,7(1):38-44.
[13] LOYOLA-LEYVA A,LOYOLA-RODRÍGUEZ J P,ATZORI M,et al.Morphological changes in erythrocytes of people with type 2 diabetes mellitus evaluated with atomic force microscopy:a brief review[J].Micron,2018,105:11-17.
[14] BUYS A V,VAN ROOY M J,SOMA P,et al.Changes in red blood cell membrane structure in type 2 diabetes:a scanning electron and atomic force microscopy study[J].Cardiovasc Diabetol,2013,12:25.
[15] KEMPE-TEUFEL D S,BISSINGER R,QADRI S M,et al.Cellular markers of eryptosis are altered in type 2 diabetes[J].Clin Chem Lab Med,2018,56(7):e177-e180.
[16] CATAN A,TURPIN C,DIOTEL N,et al.Aging and glycation promote erythrocyte phagocytosis by human endothelial cells: Potential impact in atherothrombosis under diabetic conditions[J].Atherosclerosis,2019,291:87-98.
[17] SHANTSILA E,KAMPHUISEN P W,LIP G Y.Circulating microparticles in cardiovascular disease:implications for atherogenesis and atherothrombosis[J].J Thromb Haemost,2010,8(11):2358-2368.
[18] LEKAKIS J,ABRAHAM P,BALBARINI A,et al.Methods for evaluating endothelial function:a position statement from the European Society of Cardiology Working Group on Peripheral Circulation[J].Eur J Cardiovasc Prev Rehabil,2011,18(6):775-789.
[19] FREEMAN D W,NOREN HOOTEN N,EITAN E,et al.Altered extracellular vesicle concentration,cargo,and function in diabetes[J].Diabetes,2018,67(11):2377-2388.
[20] GKALIAGKOUSI E,NIKOLAIDOU B,GAVRIILAKI E,et al.Increased erythrocyte- and platelet-derived microvesicles in newly diagnosed type 2 diabetes mellitus[J].Diabetes Vasc Dis Res,2019,16(5):458-465.
[21] KOSTARA C,BAIRAKTARI E,ELISAF M,et al.NMR-based lipidomic analysis of red blood cells membranes in type 2 diabetes[J].Diabetes,2018,67(Supplement 1):485-P.
[22] RADOSINSKA J,VRBJAR N.The role of red blood cell deformability and Na,K-ATPase function in selected risk factors of cardiovascular diseases in humans:focus on hypertension,diabetes mellitus and hypercholesterolemia[J].Physiol Res,2016,65(Suppl 1):S43-S54.
[23] LEE S,PARK H,KIM K,et al.Refractive index tomograms and dynamic membrane fluctuations of red blood cells from patients with diabetes mellitus[J].Sci Rep,2017,7(1):1039.
[24] LI Q,YANG L Z.Hemoglobin a1c level higher than 9.05% causes A significant impairment OF erythrocyte deformability IN diabetes mellitus[J].Acta Endocrinol (Buchar),2018,14(1):66-75.
[25] HUANG Z,LIU Y,MAO Y,et al.Relationship between glycated haemoglobin concentration and erythrocyte survival in type 2 diabetes mellitus determined by a modified carbon monoxide breath test[J].J Breath Res,2018,12(2):026004.
[26] MAELLARO E,LEONCINI S,MORETTI D,et al.Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients[J].Acta Diabetol,2013,50(4):489-495.
[27] KOGA M,INADA S,IJIMA H,et al.Shortened mean erythrocyte age in female patients with type 2 diabetes mellitus[J].J Clin Lab Anal,2019,33(2):e22681.
[28] GOODARZI M,MOOSAVI-MOVAHEDI A A,HABIBI-REZAEI M,et al.Hemoglobin fructation promotes heme degradation through the generation of endogenous reactive oxygen species[J].Spectrochimica Acta A:Mol Biomol Spectrosc,2014,130:561-567.
[29] TILLMANN W,MERTEN A,LAKOMEK M,et al.Flexibility of erythrocytes in juvenile diabetes mellitus[J].Blut,1981,43(2):125-128.
[30] ZHOU Z,MAHDI A,TRATSIAKOVICH Y,et al.Erythrocytes from patients with type 2 diabetes induce endothelial dysfunction via arginase I[J].J Am Coll Cardiol,2018,72(7):769-780.
[31] PERNOW J,MAHDI A,YANG J N,et al.Red blood cell dysfunction:a new player in cardiovascular disease[J].Cardiovasc Res,2019,115(11):1596-1605.
[32] YANG J,ZHENG X,MAHDI A,et al.Red blood cells in type 2 diabetes impair cardiac post-ischemic recovery through an arginase-dependent modulation of nitric oxide synthase and reactive oxygen species[J].JACC Basic Transl Sci,2018,3(4):450-463.
[33] SHAZI A,LINGAM SC,AHMAD A.A study on excess permittivity on diabetic human erythrocytes using computer aided dielectrodynamic technique[J]. Int J Sci Env,2015,4: 864-869.
[34] MINASYAN H.Mechanisms and pathways for the clearance of bacteria from blood circulation in health and disease[J].Pathophysiology,2016,23(2):61-66.
[35] 董晓蕾,阮萍,雍军光,等.空腹血糖水平对2型糖尿病患者红细胞变形和免疫功能的影响[J].中国糖尿病杂志,2015,23(9):827-831.
[36] 孟东,陈樱,靳建鸣,等.2型糖尿病患者红细胞CR1与T淋巴细胞亚群动态观察及相关性分析[J].天津医科大学学报,2002,8(1):94-96.
[37] GARVEY J S.Immunity and the red blood-cell[J].Lancet,1982,1(8265):223.
[38] 徐瑛,郭峰,叶天星.红细胞增强中性粒细胞吞噬作用及红细胞过氧化物岐化酶的临床意义[J].上海医学,1990,13(6):346-348.
[39] 孙子林,李全忠,崔巍,等.糖尿病微循环障碍临床用药专家共识[J].中国医学前沿杂志(电子版),2017,9(2):34-41.

高血糖对红细胞理化性质及免疫功能影响的研究进展^*

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	高瞻, 肖军, 李小薇, 李翠莹. 低氧诱导因子HIF-2α调控红细胞生成的研究进展*[J]. 临床输血与检验, 2021, 23(5): 561-564.
[2]	陈清艳, 王秋实. 新生儿溶血病发病机制及产前诊断研究进展^*[J]. 临床输血与检验, 2021, 23(5): 578-584.
[3]	陈荣华, 冯文斌, 周清, 李洁, 张雪睿, 兰炯采. 国内外抗体鉴定谱细胞抗原谱质量对比分析[J]. 临床输血与检验, 2021, 23(5): 617-622.
[4]	钟福铃, 梁延连, 苏宇清, 吴凡, 梁爽, 张海璇, 洪文旭, 徐筠娉. 免疫沉淀法与质谱联用检测RHD蛋白序列方法学的建立^*[J]. 临床输血与检验, 2021, 23(5): 623-627.
[5]	苑召虎, 魏亚明. 储存血细胞中非编码RNA研究进展^*[J]. 临床输血与检验, 2021, 23(4): 416-420.
[6]	张怡宇, 黄国清, 张勇刚, 苑召虎, 王强, 陈小洁, 黄建云, 李楠, 魏亚明. 储存红细胞中circRNA变化对泛素介导蛋白水解通路调控的预测分析^*[J]. 临床输血与检验, 2021, 23(4): 420-427.
[7]	张怡宇, 黄国清, 王强, 张勇刚, 苑召虎, 陈小洁, 黄建云, 李楠, 魏亚明. 储存红细胞中表达降低的circRNA以及其靶基因预测的研究^*[J]. 临床输血与检验, 2021, 23(4): 428-434.
[8]	田雅娴, 詹林盛, 王小慧, 田兆菊. 去白悬浮红细胞4 ℃储存不同时间的质量评价[J]. 临床输血与检验, 2021, 23(4): 435-442.
[9]	邸艳辉, 管行, 寇立舵, 白薇, 王新华. AIHA患者血型血清学特征及输注悬浮红细胞疗效分析[J]. 临床输血与检验, 2021, 23(4): 455-458.
[10]	程宁, 臧艳, 唐河山, 冯子阳, 钱宝华. 院前红细胞输血在平时与战时的实施现状与进展[J]. 临床输血与检验, 2021, 23(4): 530-535.
[11]	沈凌霄, 赵刚. 红细胞冷冻保存的历史、机理与研究进展[J]. 临床输血与检验, 2021, 23(3): 273-293.
[12]	邵从军. 红细胞分布宽度在临床疾病诊疗中的研究进展[J]. 临床输血与检验, 2021, 23(3): 400-404.
[13]	王慧茹, 刘会兰. 非血缘脐血移植术后患者输血情况相关影响因素分析^*[J]. 临床输血与检验, 2021, 23(2): 162-166.
[14]	胡蝶, 浦春. 可溶性ST2及其配体IL-33与疾病关系的研究进展^*[J]. 临床输血与检验, 2021, 23(1): 131-134.
[15]	郝一文. 以一种整体、动态观评估及评价红细胞输注的指征及效果[J]. 临床输血与检验, 2020, 22(6): 590-593.